Celera Settles Some Suits Related to Quest Diagnostics Acquisition
April 18, 2011
Celera Settles Some Suits Related to Quest Diagnostics Acquisition
Celera and other defendants have entered into a memorandum of understanding in putative class action lawsuits stemming from the company's proposed acquisition by Quest Diagnostics.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Following Merger, Express Scripts May Cut Back Medco's Personalized Medicine Programs
May 9, 2012 / Pharmacogenomics Reporter - MDx Firm QuantuMDx Buys NorthGene
March 1, 2013 / GenomeWeb Daily News - BGI Offer for Complete Genomics Extended Until March 1
February 25, 2013 / GenomeWeb Daily News - Quest Diagnostics Divests OralDNA Labs
December 31, 2012 / GenomeWeb Daily News - 'Omics, MDx M&A Activity Down Slightly in 2012; Rebound May Not Come Until 2014
December 27, 2012 / GenomeWeb Daily News